Stay updated on Hydroxychloroquine, Zinc, Azithromycin, Doxy Clinical Trial
Sign up to get notified when there's something new on the Hydroxychloroquine, Zinc, Azithromycin, Doxy Clinical Trial page.

Latest updates to the Hydroxychloroquine, Zinc, Azithromycin, Doxy Clinical Trial page
- Check6 days agoChange DetectedThe page now displays the ClinicalTrials.gov record for a completed COVID-19 outpatient study evaluating hydroxychloroquine and zinc with either azithromycin or doxycycline. It includes the study design, participant criteria, treatment arms, and measured outcomes.SummaryDifference58%

- Check13 days agoChange DetectedThe site revision identifier changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check20 days agoChange DetectedA banner announces NIH updates and says that some federal agencies are using “Super Intelligence” in place of “Artificial Intelligence” during a transition.SummaryDifference1%

- Check27 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check34 days agoChange DetectedThe displayed ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1; the page remains a 403 Forbidden error page.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, replacing the usual content and navigation with a standard error screen. This indicates an access issue that prevents viewing the study record.SummaryDifference20%

Stay in the know with updates to Hydroxychloroquine, Zinc, Azithromycin, Doxy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Hydroxychloroquine, Zinc, Azithromycin, Doxy Clinical Trial page.